PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
- Conditions
- Chronic Myelomonocytic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14
- Registration Number
- NCT04842604
- Locations
- 🇦🇹
Landeskrankenhaus Salzburg, Universitatsklinik fur Innere Medizin III der PMU, Salzburg, Austria
🇭🇺Debreceni Egyetem Klinikai Kozpont Belgyogyaszati Klinika, Hematologia Tanszek, Debrecen, Hungary
🇦🇹Uniklinikum Salzburg, Landeskrankenhaus Salzburg, Salzburg, Austria
A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy
- Conditions
- Healthy Volunteer
- Interventions
- Drug: PF-06882961/PF-06865571 followed by PF-06882961
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT04839393
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 22
- Registration Number
- NCT04832139
- Locations
- 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium
The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
- Conditions
- Transthyretin Amyloid Polyneuropathy (ATTR-PN)
- Interventions
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 15
- Registration Number
- NCT04828993
- Locations
- 🇨🇳
Peking union hospital of Chinese academy of medical sciences, Beijing, China
🇨🇳Tiantan Hospital Capital Medical University, Beijing, China
🇨🇳Peking University First Hospital, Beijing, Beijing, China
Monitoring Activity And Gait In Children
- Conditions
- Child, PreschoolAdolescentChild
- Interventions
- Device: Panoramic Bracelet and GENEActiv
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 87
- Registration Number
- NCT04823650
- Locations
- 🇺🇸
Pfizer Innovation Research, PfIRe, Lab, Cambridge, Massachusetts, United States
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 599
- Registration Number
- NCT04822350
- Locations
- 🇫🇷
Centre Hospitalier de Boulogne Sur Mer, BOULOGNE SUR MER Cedex, France
🇫🇷Hopital Louis Pradel, Bron Cedex, France
🇫🇷Medipole de Savoie, Challes Les Eaux, France
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 599
- Registration Number
- NCT04821622
- Locations
- 🇭🇺
Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Budapest, Hungary
🇮🇳Indraprastha Apollo Hospital, New Delhi, Delhi, India
🇮🇳Bhaktivedanta Hospital and Research Institute, Mumbai, Thane, Maharashtra, India
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
- Conditions
- Esophagitis
- Interventions
- Drug: Full dose Pantoprazole plus matching placeboDrug: Half Dose Pantoprazole plus matching placebo
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 110
- Registration Number
- NCT04821310
- Locations
- 🇬🇪
JSC Georgian Clinics, Tbilisi, Georgia
🇮🇳Medical college and Hospital, Kolkata, WEST Bengal, India
🇸🇰CLINIQ s.r.o., Bratislava, Slovakia
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
- Conditions
- Meningococcal Vaccine
- Interventions
- Biological: Nimenrix
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 149
- Registration Number
- NCT04819113
- Locations
- 🇵🇱
Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o., Krakow, Poland
🇫🇮Tampere Vaccine Research Clinic, Tampere, Pirkanmaa, Finland
🇫🇮Jarvenpaa Vaccine Research Center, Jarvenpaa, Finland
A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 53
- Registration Number
- NCT04814186
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳The Second Xiangya Hospital of Central South University, Changsha, Hunan, China